Enibarcimab
Enibarcimab is a humanized monoclonal antibody that has been investigated as a medication for the treatment of acute heart failure and COVID-19.
| Supplier | BOC Sciences |
|---|---|
| Product # | 2305638-98-4 |
| Pricing | Inquire |
| Cas | 2305638-98-4 |